Back to ACAD

Trails Edge Capital Partners, LP → ACAD

Trails Edge Capital Partners, LP ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
1
Latest value
$37.9M
Q4 2025
Peak value
$37.9M
First seen
Q4 2025

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q4 2025$37.9M1.42M——

Other funds holding ACAD

Other Trails Edge Capital Partners, LP positions

LBRX

LB PHARMACEUTICALS INC

$49.4M
LBRX

LB PHARMACEUTICALS INC

$44.1M
BMRN

BIOMARIN PHARMACEUTICAL INC

$40M
PCVX

VAXCYTE INC

$38.5M
NRIX

NURIX THERAPEUTICS INC

$38.2M
NRIX

NURIX THERAPEUTICS INC

$37.3M
OBX

OBSIDIAN THERAPEUTICS INC

$34.3M
PCVX

VAXCYTE INC

$34M